University of Rochester Medical Center seeking children 3 to 12 yrs. diagnosed with FASD or known prenatal alcohol exposure to participate in a research study. Study includes the use of an app and monetary compensation.
Quarterly meeting for parents and caregivers of a person living with FASD
A team of experts from across Canada and the US have developed the first ever medication algorithm for individuals with Fetal Alcohol Spectrum Disorder (FASD). CanFASD Research Leads Dr.’s Mansfield Mela and Ana Hanlon-Dearman and CanFASD Family Advisory Committee’s Dorothy Reid are among the co-authors of the study. This algorithm is now an important tool available for clinicians to use to treat individuals with FASD (children and adolescents aged 7 and above, and adults).